The Angel CoFund (ACF) has appointed Dr Olivia Nicoletti to the team as Senior Investment Associate. Joining from Cambridge Enterprise, where she worked on technology transfer for innovations from Cambridge University, Olivia will focus on deep tech investments for the fund.
Olivia holds a PhD from the University of Cambridge for her work in nano-optics and the equivalent of an M.Sc. and a B.Sc. in Physics from Universita’ Statale di Milano. She joins the fund from her previous role as Commercialisation Manager at Cambridge Enterprise, the technology transfer arm of the University of Cambridge, where she worked for five years helping academics to build commercial opportunities from the outcome of their research. These included a broad range of deep tech areas from quantum computing to encryption, machine learning, photovoltaics, light emission, as well as medical devices. She helped launch and fund start ups such as Nu Quantum, Colorifix, Flusso and Riverlane.
Olivia Nicoletti, Senior Investment Associate, ACF, commented: “I am thrilled to be able to bring my knowledge of deep tech and science to the Angel CoFund, to continue to help UK entrepreneurs build their businesses. I was drawn to the amazing team at ACF and the work they are doing, and believe my experience in early stage and commercialising technology is a great fit. My background in physics and the work I did at Cambridge Enterprise also gives me a unique perspective of the space; something that I am excited to deploy to support world-class businesses.”
Tim Mills, Managing Partner at ACF, commented: “We feel privileged to be able to announce such a great addition to the ACF team. Olivia brings with her years of deep tech experience and a real empathy and understanding to entrepreneurs and academics scaling world class businesses. We are delighted to be growing our team on the back of strong portfolio performance and are committed to continue to support and scale the UK’s most promising deep tech entrepreneurial talent”.
Olivia will be adding her deep tech expertise to a growing number of ACF portfolio companies in the sector as the ACF continues to look to foster growth in the deep tech sector; helping world-changing ideas become great businesses. Current deep tech portfolio companies include: Wayland Additive, an innovative metal additive manufacturing company; Oxford Drug Design which develops rapid, state-of-the-art virtual screening and ligand analogue searching technologies, and Neurovalens, pioneers in non-invasive brain stem stimulating medicine.
